Amgen
Eduard Sidelnikov is a seasoned professional in health economics and outcomes research with extensive experience in the pharmaceutical industry. Currently serving as the Global HEOR Therapeutic Area Head for General Medicine at Amgen since August 2014, Sidelnikov leads a global team focusing on cardiovascular, bone, and neurology portfolios. Previous roles at Amgen include European Health Economics Lead and Health Economics Senior Manager, where efforts concentrated on generating real-world evidence and enhancing market access strategies. Sidelnikov’s background includes an Epidemiologist position at the Center of Aging and Mobility at the University of Zurich and significant research roles at Emory University's Rollins School of Public Health. Education includes a Ph.D. in Epidemiology and a Master’s Degree in Health Economics and Pharmacoeconomics from Emory University and Universitat Pompeu Fabra, respectively.
This person is not in any teams
This person is not in any offices
Amgen
275 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.